Inventor · disambiguated record
Prashant K. Bhavar
Also filed as: BHAVAR PRASHANT K · BHAVAR PRASHANT KASHINATH
17 granted patents·8 pending applications·15 citations·filing 2011–2024
90Inventor score
Files withRHIZEN PHARMACEUTICALS SA19VRISE THERAPEUTICS INC3MUTHUPPALANIAPPAN MEYYAPPAN1NAGARATHNAM DHANAPALAN1RHIZEN PHARMACEUTICALS AG1
Top patents by PatentIndex Score
25 records- 0183US9815831B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2013·Granted Nov 14, 2017·5 cites·32 claims
- 0281US10220035B2Compounds as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Mar 5, 2019·2 cites·12 claims
- 0380US9783533B2Glutaminase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Oct 10, 2017·4 cites·13 claims
- 0475US9775841B2Compounds as modulators of protein kinasesNAGARATHNAM DHANAPALAN·Filed 2012·Granted Oct 3, 2017·2 cites·6 claims
- 0574US2021401840A1Novel compounds as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 0670US11466006B2Dual selective PI3 delta and gamma kinase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2020·Granted Oct 11, 2022·0 cites·10 claims
- 0770US11020399B2Intermediates useful in the synthesis of compounds as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Jun 1, 2021·0 cites·2 claims
- 0870US9758474B2Immunomodulator and anti-inflammatory compoundsRHIZEN PHARMACEUTICALS SA·Filed 2014·Granted Sep 12, 2017·1 cites·8 claims
- 0969US8686048B2Immunomodulator and anti-inflammatory compoundsMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2011·Granted Apr 1, 2014·1 cites·7 claims
- 1068US2021371416A1Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5- disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 1166US2020199133A1Selective dual inhibitors of pi3 delta and gamma protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
- 1264US2021032236A1Novel glutaminase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
- 1362US9790224B2Dual selective PI3 delta and gamma kinase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2014·Granted Oct 17, 2017·0 cites·32 claims
- 1461US10851107B2Dual selective P13 delta and gamma kinase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Dec 1, 2020·0 cites·23 claims
- 1561US10611759B2Glutaminase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Apr 7, 2020·0 cites·25 claims
- 1661US10322130B2Substituted chromenones as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Jun 18, 2019·0 cites·35 claims
- 1761US10179786B2Selective dual inhibitors of PI3 delta and gamma protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Jan 15, 2019·0 cites·5 claims
- 1861US2025163032A1Novel molecules as inhibitors of dna damage repair pathwayVRISE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1961US2019202836A1Selective dual inhibitors of pi3 delta and gamma protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 2061US2025051361A15,6,7,8-tetrahydro-2,6-naphthyridine derivatives as cancer therapeuticsVRISE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2161US2024300942A1Small molecules for treatement of cancerVRISE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2257US12428422B2Purine derivatives as SIK-3 inhibitorsRHIZEN PHARMACEUTICALS AG·Filed 2021·Granted Sep 30, 2025·0 cites·6 claims
- 2357US9708329B2Selective dual inhibitors of PI3 delta and gamma protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Jul 18, 2017·0 cites·10 claims
- 2455US11066402B23,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Jul 20, 2021·0 cites·19 claims
- 2546US11352359B2PI3K protein kinase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2014·Granted Jun 7, 2022·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Prashant K. Bhavar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →